feed,title,long_url,short_url
SeekingAlpha,Neurocrine Biosciences: Taking Advantage Of A Shrinking Share Price Ahead Of Projected Growth,https://seekingalpha.com/article/4482828,
SeekingAlpha,White Brook Capital Q4 2021 Commentary,https://seekingalpha.com/article/4482827,
